The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

17 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
23
Structure-Based Design of New LSD1/EGFRL858R/T790M Dual Inhibitors for Treating EGFR Mutant NSCLC Cancers.EBI
Zhengzhou University
38
Combination Therapy and Dual-Target Inhibitors Based on LSD1: New Emerging Tools in Cancer Therapy.EBI
Zhengzhou University
9
Dual inhibitors of HDAC and other epigenetic regulators: A novel strategy for cancer treatment.EBI
Guru Ghasidas University
17
Design, synthesis, and structure-activity relationship of TAK-418 and its derivatives as a novel series of LSD1 inhibitors with lowered risk of hematological side effects.EBI
Takeda Pharmaceutical
26
Structural and Functional Landscape of FAD-Dependent Histone Lysine Demethylases for New Drug Discovery.EBI
Zhengzhou University
17
Research progress of dual inhibitors targeting crosstalk between histone epigenetic modulators for cancer therapy.EBI
Xinxiang Medical University
6
Design, Synthesis, and Evaluation of [EBI
Takeda Pharmaceutical
32
Reversible Lysine Specific Demethylase 1 (LSD1) Inhibitors: A Promising Wrench to Impair LSD1.EBI
Zhengzhou University
47
Drug discovery of histone lysine demethylases (KDMs) inhibitors (progress from 2018 to present).EBI
Hangzhou Normal University
36
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models.EBI
Sapienza University of Rome
11
Structure-Based Identification of Potent Lysine-Specific Demethylase 1 Inhibitor Peptides and Temporary Cyclization to Enhance Proteolytic Stability and Cell Growth-Inhibitory Activity.EBI
Nagoya City University
36
Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.EBI
Key Laboratory of Henan Provinc
2
Aminotriazole and Aminotetrazole Inhibitors of LSD1 as Epigenetic Modulators.EBI
Dart Neuroscience
14
Histone lysine specific demethylase 1 inhibitors.EBI
Taipei Medical University
3
3,5-Diamino-1,2,4-triazoles as a novel scaffold for potent, reversible LSD1 (KDM1A) inhibitors.EBI
Medical University of South Carolina
28
Further insights into the SAR of α-substituted cyclopropylamine derivatives as inhibitors of histone demethylase KDM1A.EBI
University of Parma
5
Cyclic peptide inhibitors of lysine-specific demethylase 1 with improved potency identified by alanine scanning mutagenesis.EBI
Medical University of South Carolina